Medical Technology

@techcrunch.com 2 years ago

Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”

@xconomy.com 3 years ago

Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

@xconomy.com 4 years ago

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@xconomy.com 5 years ago

Former Zavante Executive Tapped as Abide Therapeutics President

@techcrunch.com 6 years ago

Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks